BTC Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$477K	Buy	2,390 +247	+12%	+$48.9K	0.03%	179
2025 Q4	$406K	Sell	2,143 -853	-28%	-$164K	0.03%	183
2025 Q3	$531K	Sell	2,996 -427	-12%	-$63.5K	0.04%	163
2025 Q2	$389K	Buy	3,423 +327	+11%	+$35K	0.03%	175
2025 Q1	$326K	Sell	3,096 -208	-6%	-$23.5K	0.03%	186
2024 Q4	$354K	Sell	3,304 -131	-4%	-$14.8K	0.03%	182
2024 Q3	$344K	Sell	3,435 -834	-20%	-$84K	0.03%	193
2024 Q2	$360K	Sell	4,269 -336	-7%	-$26.7K	0.03%	182
2024 Q1	$337K	Buy	+4,605	New	+$340K	0.03%	194
2023 Q3	$263K	Buy	4,386 +658	+18%	+$43.3K	0.03%	201
2023 Q2	$268K	Buy	3,728 +47	+1%	+$3.53K	0.03%	212
2023 Q1	$270K	Buy	+3,681	New	+$262K	0.03%	202
2022 Q4	–	Sell	-4,312	Closed	-$232K	–	252
2022 Q3	$232K	Buy	4,312 +691	+19%	+$40.6K	0.03%	228
2022 Q2	$202K	Sell	3,621 -475	-12%	-$27K	0.02%	250
2022 Q1	$288K	Sell	4,096 -134	-3%	-$9.72K	0.03%	239
2021 Q4	$408K	Buy	+4,230	New	+$391K	0.04%	206
2021 Q2	–	Sell	-2,445	Closed	-$233K	–	225
2021 Q1	$233K	Sell	2,445 -973	-28%	-$92K	0.03%	217
2020 Q4	$212K	Buy	+3,418	New	+$195K	0.03%	215